{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T09:07:27Z","timestamp":1746090447960,"version":"3.37.3"},"reference-count":19,"publisher":"Bentham Science Publishers Ltd.","issue":"7","funder":[{"DOI":"10.13039\/501100001807","name":"S\u00e3o Paulo Research Foundation","doi-asserted-by":"publisher","award":["2017\/01249-3"],"award-info":[{"award-number":["2017\/01249-3"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CDT"],"published-print":{"date-parts":[[2022,7]]},"abstract":"<jats:sec>\n<jats:title>Background:<\/jats:title>\n<jats:p>Neglected tropical diseases (NTDs) are infectious diseases that mostly af-fect people living in tropical and subtropical regions, especially in impoverished areas. Ubiquitously found in plants, flavonoids are a group of compounds that have been reported to exhibit a wide range of biological activities against parasites (Leishmania sp., Trypanosoma cruzi, Trypanosoma brucei, Brugia malayi, etc.) that cause certain NTDs.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Aims:<\/jats:title>\n<jats:p>The present study aims to highlight and discuss our recent reports on the implication of fla-vonoids in drug development for NTDs, such as leishmaniasis, Chagas disease, African trypanoso-miasis, filariasis, among others.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Results:<\/jats:title>\n<jats:p>Today, studies show that flavonoids exhibit in vitro antileishmanial, anti-trypanosomiasis, antifilarial activities, among others. Furthermore, the molecular hybridization of flavonoids with the triazole groups has led to the development of compounds with improved biological activity. The in-corporation of chemical groups, such as NO2, F, and Cl groups, during the process of design and synthesis, leads to the enhancement of pharmacological activity.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Conclusion:<\/jats:title>\n<jats:p>Flavonoids are useful metabolites that can be prospected as potential leads for the de-velopment of new agents against certain NTDs. However, research opportunities, including cytotox-icity and in vivo studies, mechanisms of action, bioavailability of these compounds, remain to be investigated in the future.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/1389450123666220309093827","type":"journal-article","created":{"date-parts":[[2022,3,10]],"date-time":"2022-03-10T04:35:07Z","timestamp":1646886907000},"page":"680-682","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Therapeutic Potential of Flavonoid Derivatives for Certain Neglected\nTropical Diseases"],"prefix":"10.2174","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4982-0507","authenticated-orcid":true,"given":"Boniface Kamdem","family":"Pone","sequence":"first","affiliation":[{"name":"Department of Pharmacy, Faculty of Pharmaceutical Sciences, University of S\u00e3o Paulo, S\u00e3o Paulo, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3833-3439","authenticated-orcid":true,"given":"Elizabeth Igne","family":"Ferreira","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Faculty of Pharmaceutical Sciences, University of S\u00e3o Paulo, S\u00e3o Paulo, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"965","reference":[{"year":"2021","key":"ref=1","unstructured":"World Health Organization (WHO)Available from:\n[Accessed on 9th Feb 2022].2021"},{"key":"ref=2","author":"Jannin J.","year":"2013","unstructured":"Jannin J.; Gabrielli A.F.;  In Handbook of Clinical Neurology  Neuroparasitology and tropical neurology. Available from:\n [Accessed on 9th Feb 2022].2013","journal-title":"In Handbook of Clinical Neurology"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.jconrel.2021.09.020","volume":"339","author":"Joshi G.","year":"2021","unstructured":"Joshi G.; Quadir S.S.; Yadav K.S.; Road map to the treatment of neglected tropical diseases: Nanocarriers interventions. J Control Release 2021,339,51-74","journal-title":"J Control Release"},{"key":"ref=4","doi-asserted-by":"publisher","DOI":"10.1016\/C2017-0-02265-6","author":"Campos M.R.S.","year":"2019","unstructured":"Campos M.R.S.;  Bioactive compounds health benefits and potential applications 2019","journal-title":"Bioactive compounds health benefits and potential applications"},{"key":"ref=5","doi-asserted-by":"publisher","DOI":"10.1155\/2013\/162750","volume":"2013","author":"Kumar S.","year":"2013","unstructured":"Kumar S.; Pandey A.K.; Chemistry and biological activities of flavonoids: An overview. ScientificWorldJ 2013,2013","journal-title":"ScientificWorldJ"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.2174\/1389450120666190618114857","volume":"20","author":"Boniface P.K.","year":"2019","unstructured":"Boniface P.K.; Elizabeth F.I.; Flavonoid-derived privileged scaffolds in anti-Trypanosoma brucei drug discovery. Curr Drug Targets 2019,20(12),1295-1314","journal-title":"Curr Drug Targets"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"657","DOI":"10.2174\/1389450120666191204152415","volume":"21","author":"Boniface P.K.","year":"2020","unstructured":"Boniface P.K.; Elizabeth F.I.; An insight into the discovery of potent antifilarial leads against lymphatic filariasis. Curr Drug Targets 2020,21(7),657-680","journal-title":"Curr Drug Targets"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"681","DOI":"10.2174\/1389450121666200128112948","volume":"21","author":"Boniface P.K.","year":"2020","unstructured":"Boniface P.K.; Sano C.M.; Elizabeth F.I.; Unveiling the targets involved in quest of antileishmanial leads using in-silico methods. Curr Drug Targets 2020,21(7),681-712","journal-title":"Curr Drug Targets"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"379","DOI":"10.2174\/1389450121666201228122239","volume":"22","author":"Kamdem B.P.","year":"2021","unstructured":"Kamdem B.P.; Elizabeth F.I.; The role of nitro (NO2-), chloro (Cl-), and fluoro (F-) substitution in the design of antileishmanial and antichagasic compounds. Curr Drug Targets 2021,22(4),379-398","journal-title":"Curr Drug Targets"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"33","DOI":"10.2174\/1389450122666210412125643","volume":"23","author":"Pone K.B.","year":"2022","unstructured":"Pone K.B.; Dalhatou S.; Paumo H.K.; Katata-Seru L.M.; Ferreira E.I.; Triazole-containing heterocycles: Privileged scaffolds in anti-Trypanosoma cruzi drug development. Curr Drug Targets 2022,23(1),33-59","journal-title":"Curr Drug Targets"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"3179","DOI":"10.1016\/j.ejmech.2011.05.013","volume":"46","author":"Pluta K.","year":"2011","unstructured":"Pluta K.; Morak-M;odawska B, Jele M. Recent progress in biological activities of synthesized phenothiazines. Eur J Med Chem 2011,46(8),3179-3189","journal-title":"Eur J Med Chem"},{"key":"ref=12","first-page":"246","volume":"127","author":"Subrahmanyam D.","year":"1987","unstructured":"Subrahmanyam D.; Antifilarials and their mode of action. Ciba Found Symp 1987,127,246-264","journal-title":"Ciba Found Symp"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4172\/2161-1009.1000e147","volume":"3","author":"Sharma B.","year":"2014","unstructured":"Sharma B.; Lymphatic filariasis and chemotherapeutic targets. Biochem Anal Biochem 2014,3(2),1","journal-title":"Biochem Anal Biochem"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1080\/00034983.1978.11719278","volume":"72","author":"Polak A.","year":"1978","unstructured":"Polak A.; Richle R.; Mode of action of the 2-nitroimidazole derivative benznidazole. Ann Trop Med Parasitol 1978,72(1),45-54","journal-title":"Ann Trop Med Parasitol"},{"year":"2019","author":"Cirqueira ML","key":"ref=15","unstructured":"Cirqueira ML; Structural studies on Trypanosoma cruzi nitroreductase enzyme: Characterization of prodrug activation mechanism for benznidazole and nifurtimox  752019"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"303","DOI":"10.2174\/138945010790711996","volume":"11","author":"Hernandes M.Z.","year":"2010","unstructured":"Hernandes M.Z.; Cavalcanti S.M.; Moreira D.R.; de Azevedo Junior W.F.; Leite A.C.; Halogen atoms in the modern medicinal chemistry: Hints for the drug design. Curr Drug Targets 2010,11(3),303-314","journal-title":"Curr Drug Targets"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1002\/cbic.200400017","volume":"5","author":"Gerebtzoff G.","year":"2004","unstructured":"Gerebtzoff G.; Li-Blatter X.; Fischer H.; Frentzel A.; Seelig A.; Halogenation of drugs enhances membrane binding and permeation. ChemBioChem 2004,5(5),676-684","journal-title":"ChemBioChem"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"3770","DOI":"10.1128\/AAC.00578-06","volume":"50","author":"Naguleswaran A.","year":"2006","unstructured":"Naguleswaran A.; Spicher M.; Vonlaufen N.; In vitro metacestodicidal activities of genistein and other isoflavones against Echinococcus multilocularis and Echinococcus granulosus. Antimicrob Agents Chemother 2006,50(11),3770-3778","journal-title":"Antimicrob Agents Chemother"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"1853","DOI":"10.1292\/jvms.19-0347","volume":"81","author":"Xin Q.","year":"2019","unstructured":"Xin Q.; Yuan M.; Li H.; Lu J.; Song X.; Jing T.; In vitro efficacy of ampelopsin against Echinococcus granulosus and Echinococcus multilocularis. J Vet Med Sci 2019,81(12),1853-1858","journal-title":"J Vet Med Sci"}],"container-title":["Current Drug Targets"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1389450123666220309093827","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/201927\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1389450123666220309093827","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,2]],"date-time":"2022-08-02T17:04:48Z","timestamp":1659459888000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/201927\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7]]},"references-count":19,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2022,7]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1389450123666220309093827","relation":{},"ISSN":["1389-4501"],"issn-type":[{"type":"print","value":"1389-4501"}],"subject":[],"published":{"date-parts":[[2022,7]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2021-11-22","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-12-13","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-01-13","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-06-29","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}